NO951015D0 - Serotoninreseptormidler - Google Patents
SerotoninreseptormidlerInfo
- Publication number
- NO951015D0 NO951015D0 NO951015A NO951015A NO951015D0 NO 951015 D0 NO951015 D0 NO 951015D0 NO 951015 A NO951015 A NO 951015A NO 951015 A NO951015 A NO 951015A NO 951015 D0 NO951015 D0 NO 951015D0
- Authority
- NO
- Norway
- Prior art keywords
- represented
- hydrogen
- alkyl
- optionally substituted
- chx1
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D333/56—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D333/58—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D333/60—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D333/70—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Confectionery (AREA)
- Jellies, Jams, And Syrups (AREA)
- Materials For Medical Uses (AREA)
- Dental Preparations (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US94700792A | 1992-09-17 | 1992-09-17 | |
| US7969293A | 1993-06-17 | 1993-06-17 | |
| US08/119,791 US5436246A (en) | 1992-09-17 | 1993-09-15 | Serotonin receptor agents |
| PCT/US1993/008865 WO1994006789A1 (en) | 1992-09-17 | 1993-09-17 | Serotonin receptor agents |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO951015D0 true NO951015D0 (no) | 1995-03-16 |
| NO951015L NO951015L (no) | 1995-05-15 |
| NO310461B1 NO310461B1 (no) | 2001-07-09 |
Family
ID=27373532
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO19951015A NO310461B1 (no) | 1992-09-17 | 1995-03-16 | Serotoninreseptormidler |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US5436246A (no) |
| EP (1) | EP0660832B1 (no) |
| JP (1) | JP3298107B2 (no) |
| KR (1) | KR100195809B1 (no) |
| AT (1) | ATE162190T1 (no) |
| AU (1) | AU671494B2 (no) |
| CA (1) | CA2144947C (no) |
| DE (1) | DE69316377T2 (no) |
| ES (1) | ES2112434T3 (no) |
| FI (1) | FI951249A0 (no) |
| GR (1) | GR3026297T3 (no) |
| HU (1) | HU222725B1 (no) |
| NO (1) | NO310461B1 (no) |
| NZ (1) | NZ256561A (no) |
| WO (1) | WO1994006789A1 (no) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SK278998B6 (sk) * | 1991-02-01 | 1998-05-06 | Merck Sharp & Dohme Limited | Deriváty imidazolu, triazolu a tetrazolu, spôsob i |
| JP3155008B2 (ja) * | 1994-07-26 | 2001-04-09 | ファイザー・インコーポレーテッド | セロトニンアゴニストおよびアンタゴニストとしての４−インドール誘導体 |
| FR2735127B1 (fr) * | 1995-06-09 | 1997-08-22 | Pf Medicament | Nouvelles piperazines heteroaromatiques utiles comme medicaments. |
| GB9517381D0 (en) * | 1995-08-24 | 1995-10-25 | Pharmacia Spa | Aryl and heteroaryl piperazine derivatives |
| US6225312B1 (en) | 1996-03-29 | 2001-05-01 | Duphar International Research B.V. | Piperazine and piperidine compounds |
| ES2246058T3 (es) * | 1996-03-29 | 2006-02-01 | Pfizer Inc. | Derivados bencil(iden)-lactama, su preparacion y su uso como (ant)agonistas selectivos de receptores 5-ht1a y/o 5-ht1d. |
| FR2761068B1 (fr) * | 1997-03-20 | 1999-04-23 | Synthelabo | Derives de piperazin-4-ylthieno[3,2-c]pyridin-4-yl-2- carboxamide, leur preparation et leur application en therapeutique |
| FR2763243A1 (fr) * | 1997-05-14 | 1998-11-20 | Pf Medicament | Utilisation d'amines indoliques comme medicaments antithrombotiques |
| EP0900792B1 (en) * | 1997-09-02 | 2003-10-29 | Duphar International Research B.V | Piperazine and piperidine derivatives as 5-HT1A and dopamine D2-receptor (ant)agonists |
| TW530054B (en) | 1997-09-24 | 2003-05-01 | Duphar Int Res | New piperazine and piperidine compounds |
| US7189753B1 (en) | 1997-11-06 | 2007-03-13 | Cady Roger K | Preemptive prophylaxis of migraine |
| DE60015146T2 (de) * | 1999-07-29 | 2006-02-16 | Eli Lilly And Co., Indianapolis | Serotonerge benzothiophene |
| GB0005789D0 (en) | 2000-03-11 | 2000-05-03 | Knoll Ag | Therapeutic agents |
| US6969730B2 (en) * | 2001-03-16 | 2005-11-29 | Abbott Laboratories | Amines as histamine-3 receptor ligands and their therapeutic applications |
| CA2440238C (en) * | 2001-03-16 | 2011-09-13 | Abbott Laboratories | Novel amines as histamine-3 receptor ligands and their therapeutic applications |
| US20050080084A1 (en) * | 2003-07-11 | 2005-04-14 | Pharmacia Corporation | Compositions of a cyclooxygenase-2 selective inhibitor and a serotonin-modulating agent for the treatment of central nervous system damage |
| CA2536340A1 (en) * | 2003-08-22 | 2005-03-03 | Pharmacia Corporation | Compositions of a cyclooxygenase-2 selective inhibitor and a serotonin modulating agent for the treatment of neoplasia |
| US20050261347A1 (en) * | 2003-10-24 | 2005-11-24 | Wyeth | Dihydrobenzofuranyl alkanamine derivatives and methods for using same |
| US7435837B2 (en) * | 2003-10-24 | 2008-10-14 | Wyeth | Dihydrobenzofuranyl alkanamine derivatives and methods for using same |
| WO2006101454A1 (en) * | 2005-03-21 | 2006-09-28 | S*Bio Pte Ltd | Benzothiophene derivatives: preparation and pharmaceutical applications |
| RU2402549C3 (ru) * | 2005-04-14 | 2022-03-10 | Оцука Фармасьютикал Ко., Лтд. | Пиперазин-замещенные бензотиофены для лечения психических расстройств |
| JP4315393B2 (ja) * | 2005-04-14 | 2009-08-19 | 大塚製薬株式会社 | 複素環化合物 |
| TWI320783B (en) | 2005-04-14 | 2010-02-21 | Otsuka Pharma Co Ltd | Heterocyclic compound |
| CN101163689A (zh) * | 2005-04-22 | 2008-04-16 | 惠氏公司 | {[(2r)-7-(2，6-二氯苯基)-5-氟-2，3-二氢-1-苯并呋喃-2-基]甲基}胺盐酸盐的晶形 |
| WO2012087229A1 (en) * | 2010-12-20 | 2012-06-28 | Astrazeneca Ab | 2-carboxamide-4-piperazinyl-benzofuran derivative |
| JP5832558B2 (ja) * | 2011-07-28 | 2015-12-16 | 大塚製薬株式会社 | ベンゾ［ｂ］チオフェン化合物の製造方法 |
| CN104557896A (zh) | 2013-10-18 | 2015-04-29 | 沈敬山 | 布瑞哌唑、其关键中间体及其盐的制备方法 |
| CN105732572A (zh) * | 2014-12-10 | 2016-07-06 | 苏州鹏旭医药科技有限公司 | 一种Brexpiprazole中间体的制备方法及Brexpiprazole中间体 |
| EP3150591A1 (en) | 2015-10-02 | 2017-04-05 | Crystal Pharma S.A.U | Process and intermediates for the preparation of benzo[b]thiophene compounds |
| CN107663384B (zh) * | 2016-07-20 | 2020-05-12 | 上海高驰资产管理有限公司 | 一种荧光染料及其制备方法和用途 |
| WO2020183011A1 (en) | 2019-03-14 | 2020-09-17 | Institut Curie | Htr1d inhibitors and uses thereof in the treatment of cancer |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ209876A (en) * | 1983-10-17 | 1988-03-30 | Duphar Int Res | Piperazines and pharmaceutical compositions |
| GB8406906D0 (en) * | 1984-03-16 | 1984-04-18 | Akzo Nv | Benzo-thiazole and benzothiophene derivatives |
| ATE44528T1 (de) * | 1984-12-21 | 1989-07-15 | Duphar Int Res | Arzneimittel mit antipsychotischer wirkung. |
| ATE81975T1 (de) * | 1984-12-21 | 1992-11-15 | Duphar Int Res | Arzneimittel mit psychotroper wirkung. |
| DE58902111D1 (de) * | 1988-03-16 | 1992-10-01 | Ciba Geigy Ag | Thioverbindungen. |
| NL8802997A (nl) * | 1988-12-07 | 1990-07-02 | Philips Nv | Weergeefinrichting. |
| US5032598A (en) * | 1989-12-08 | 1991-07-16 | Merck & Co., Inc. | Nitrogens containing heterocyclic compounds as class III antiarrhythmic agents |
| FR2655988B1 (fr) * | 1989-12-20 | 1994-05-20 | Adir Cie | Nouveaux derives de la napht-1-yl piperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| DK203990D0 (da) * | 1990-08-24 | 1990-08-24 | Novo Nordisk As | Piperazinylderivater |
-
1993
- 1993-09-15 US US08/119,791 patent/US5436246A/en not_active Expired - Lifetime
- 1993-09-17 HU HU9500796A patent/HU222725B1/hu not_active IP Right Cessation
- 1993-09-17 ES ES93922253T patent/ES2112434T3/es not_active Expired - Lifetime
- 1993-09-17 KR KR1019950701026A patent/KR100195809B1/ko not_active Expired - Fee Related
- 1993-09-17 WO PCT/US1993/008865 patent/WO1994006789A1/en not_active Ceased
- 1993-09-17 FI FI951249A patent/FI951249A0/fi unknown
- 1993-09-17 AU AU51321/93A patent/AU671494B2/en not_active Ceased
- 1993-09-17 AT AT93922253T patent/ATE162190T1/de not_active IP Right Cessation
- 1993-09-17 NZ NZ256561A patent/NZ256561A/en unknown
- 1993-09-17 CA CA002144947A patent/CA2144947C/en not_active Expired - Fee Related
- 1993-09-17 EP EP93922253A patent/EP0660832B1/en not_active Expired - Lifetime
- 1993-09-17 JP JP50837194A patent/JP3298107B2/ja not_active Expired - Fee Related
- 1993-09-17 DE DE69316377T patent/DE69316377T2/de not_active Expired - Fee Related
-
1995
- 1995-03-16 NO NO19951015A patent/NO310461B1/no not_active IP Right Cessation
-
1998
- 1998-03-06 GR GR980400468T patent/GR3026297T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE69316377D1 (de) | 1998-02-19 |
| KR950703558A (ko) | 1995-09-20 |
| FI951249L (fi) | 1995-03-16 |
| ATE162190T1 (de) | 1998-01-15 |
| CA2144947C (en) | 2000-02-01 |
| EP0660832B1 (en) | 1998-01-14 |
| NZ256561A (en) | 1996-06-25 |
| NO951015L (no) | 1995-05-15 |
| JPH08501559A (ja) | 1996-02-20 |
| EP0660832A1 (en) | 1995-07-05 |
| US5436246A (en) | 1995-07-25 |
| KR100195809B1 (ko) | 1999-06-15 |
| AU5132193A (en) | 1994-04-12 |
| JP3298107B2 (ja) | 2002-07-02 |
| WO1994006789A1 (en) | 1994-03-31 |
| FI951249A7 (fi) | 1995-03-16 |
| FI951249A0 (fi) | 1995-03-16 |
| NO310461B1 (no) | 2001-07-09 |
| HU9500796D0 (en) | 1995-05-29 |
| HUT72662A (en) | 1996-05-28 |
| HU222725B1 (hu) | 2003-09-29 |
| DE69316377T2 (de) | 1998-08-27 |
| AU671494B2 (en) | 1996-08-29 |
| CA2144947A1 (en) | 1994-03-31 |
| GR3026297T3 (en) | 1998-06-30 |
| ES2112434T3 (es) | 1998-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI951249A0 (fi) | Serotiinireseptoriaineita | |
| AU2001272476A1 (en) | Piperidines for use as orexin receptor antagonists | |
| CO5080804A1 (es) | Derivados biciclicos del acido hidroxamico | |
| US4152514A (en) | 9α,5-Nitrilo-9-deoxy-PGF1 compounds | |
| DE69423802D1 (de) | Indolderivate als 5-HT1-like Agonisten | |
| ES8203845A1 (es) | Procedimiento para preparar derivados de piridoxina | |
| ES8506633A1 (es) | Un procedimiento para la preparacion de dihidropiridinas. | |
| PL143900B1 (en) | Method of obtaining new derivatives of dihydropyridine | |
| BG102959A (en) | Benzooxazinon antagonists of domamine d4 receptor | |
| FI834730A0 (fi) | 1-karboxialkanoylperhydro-indol-2-karboxylsyror och deras derivat | |
| FI101148B (fi) | Parannettu menetelmä 4-£2-(di-n-propyyliamino)etyyli|-1,3-dihydro-2H-i ndol-2-onin valmistamiseksi ja uusi välituote | |
| ES8609304A1 (es) | Procedimiento para la obtencion de derivados de indol | |
| ES8500935A1 (es) | Un procedimiento para preparar derivados de piridina. | |
| EP0379085A3 (de) | Phenylalkylamine und diese enthaltende Fungizide | |
| EP0076089A3 (en) | Azabicycloalkane derivatives, process for their preparation, and a pharmaceutical composition containing them | |
| IE812913L (en) | Sulphonyl azabicyclo benzamides | |
| ATE28639T1 (de) | Derivate von 4-(3-alkynyloxy-2-hydroxy-propyl)piperazin-1-yl-n-phenylacetamid, ihre herstellung und ihre therapeutische verwendung. | |
| AR018180A1 (es) | Procedimiento para la preparacion de acidos hidroxamicos | |
| ES8502699A1 (es) | Procedimiento para la obtencion de tetrahidrotiopiran-3, 5-dion-4-carboxamidas | |
| ES8105981A1 (es) | Procedimiento para la preparacion de derivados de 4-(nafta- leniloxi)piperidina | |
| ES8506605A1 (es) | Procedimiento de preparacion de eteres oximas basicos y de sus sales de adicion acidas | |
| AU589671B2 (en) | New textraoxo compounds | |
| ES8800663A1 (es) | Procedimiento para preparar compuestos arilsulfonicos. | |
| FI865057A0 (fi) | Nya fluorhaltiga 1,4-dihydropyridiner, foerfarande foer deras framstaellning och deras anvaendning som laekemedel. | |
| ES8307233A1 (es) | Procedimiento para preparar derivados del acido 1,4-tiazan-3-carboxilico. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |